Dai W, Zhou J, Chen T
Mol Cancer. 2024; 23(1):201.
PMID: 39285475
PMC: 11404010.
DOI: 10.1186/s12943-024-02103-x.
Jia W, Li N, Wang J, Gong X, Ouedraogo S, Wang Y
EPMA J. 2024; 15(2):375-404.
PMID: 38841623
PMC: 11148001.
DOI: 10.1007/s13167-024-00359-3.
Lu P, Deng S, Liu J, Xiao Q, Zhou Z, Li S
MedComm (2020). 2024; 5(6):e576.
PMID: 38827027
PMC: 11141500.
DOI: 10.1002/mco2.576.
Wu Y, Chen W, Miao H, Xu T
BMC Cancer. 2024; 24(1):210.
PMID: 38360598
PMC: 10870498.
DOI: 10.1186/s12885-024-11965-9.
Timofeeva A, Fedorov I, Asaturova A, Sannikova M, Tregubova A, Mayboroda O
Int J Mol Sci. 2023; 24(15).
PMID: 37569592
PMC: 10419267.
DOI: 10.3390/ijms241512214.
Kinesin family member 23 knockdown inhibits cell proliferation and epithelial-mesenchymal transition in esophageal carcinoma by inactivating the Wnt/β-catenin pathway.
Xu Q, Li X, Li Y, Yu J, Yang A
Funct Integr Genomics. 2023; 23(2):154.
PMID: 37162618
DOI: 10.1007/s10142-023-01088-y.
MiR-588 acts as an oncogene in ovarian cancer and increases the radioresistance of ovarian cancer cells.
Su X, Wang B, Zhang B, Pan S
J Radiat Res. 2023; .
PMID: 37154623
PMC: 10214998.
DOI: 10.1093/jrr/rrad033.
KIF23, under regulation by androgen receptor, contributes to nasopharyngeal carcinoma deterioration by activating the Wnt/β-catenin signaling pathway.
Xu H, Liu J, Zhang Y, Zhou Y, Zhang L, Kang J
Funct Integr Genomics. 2023; 23(2):116.
PMID: 37010644
DOI: 10.1007/s10142-023-01044-w.
Identification of CPT2 as a prognostic biomarker by integrating the metabolism-associated gene signature in colorectal cancer.
Liu J, Li Y, Xiao Q, Li Y, Peng Y, Gan Y
BMC Cancer. 2022; 22(1):1038.
PMID: 36195841
PMC: 9531485.
DOI: 10.1186/s12885-022-10126-0.
Deregulated miRNA clusters in ovarian cancer: Imperative implications in personalized medicine.
Kandettu A, Adiga D, Devi V, Suresh P, Chakrabarty S, Radhakrishnan R
Genes Dis. 2022; 9(6):1443-1465.
PMID: 36157483
PMC: 9485269.
DOI: 10.1016/j.gendis.2021.12.026.
Identification of KIF23 as a Prognostic Biomarker Associated With Progression of Clear Cell Renal Cell Carcinoma.
Wu Z, Song Y, Wu Y, Ge L, Liu Z, Du T
Front Cell Dev Biol. 2022; 10:839821.
PMID: 35478956
PMC: 9035542.
DOI: 10.3389/fcell.2022.839821.
Sequence Requirements for miR-424-5p Regulating and Function in Cancers.
Xuan J, Liu Y, Zeng X, Wang H
Int J Mol Sci. 2022; 23(7).
PMID: 35409396
PMC: 8999618.
DOI: 10.3390/ijms23074037.
miR-30a-5p promotes glomerular podocyte apoptosis via DNMT1-mediated hypermethylation under hyperhomocysteinemia.
Ding N, Xie L, Ma F, Ma S, Xiong J, Lu G
Acta Biochim Biophys Sin (Shanghai). 2022; 54(1):126-136.
PMID: 35130620
PMC: 9909319.
DOI: 10.3724/abbs.2021005.
Repression of lncRNA PART1 attenuates ovarian cancer cell viability, migration and invasion through the miR-503-5p/FOXK1 axis.
Li B, Lou G, Zhang J, Cao N, Yu X
BMC Cancer. 2022; 22(1):124.
PMID: 35100978
PMC: 8802513.
DOI: 10.1186/s12885-021-09005-x.
A microRNA Cluster Controls Fat Cell Differentiation and Adipose Tissue Expansion By Regulating SNCG.
Rodriguez-Barrueco R, Latorre J, Devis-Jauregui L, Lluch A, Bonifaci N, Llobet F
Adv Sci (Weinh). 2021; 9(4):e2104759.
PMID: 34898027
PMC: 8811811.
DOI: 10.1002/advs.202104759.
MiRNA-424-5p Suppresses Proliferation, Migration, and Invasion of Clear Cell Renal Cell Carcinoma and Attenuates Expression of O-GlcNAc-Transferase.
Kalantzakos T, Sullivan T, Gloria T, Canes D, Moinzadeh A, Rieger-Christ K
Cancers (Basel). 2021; 13(20).
PMID: 34680309
PMC: 8533684.
DOI: 10.3390/cancers13205160.
Development and Validation of a Prognostic Nomogram Based on DNA Methylation-Driven Genes for Patients With Ovarian Cancer.
Zhou M, Hong S, Li B, Liu C, Hu M, Min J
Front Genet. 2021; 12:675197.
PMID: 34567062
PMC: 8458765.
DOI: 10.3389/fgene.2021.675197.
[MicroRNA-424 inhibits autophagy and proliferation of hepatocellular carcinoma cells by targeting ATG14].
Zhao Z, Huang W, He J, Feng C
Nan Fang Yi Ke Da Xue Xue Bao. 2021; 41(7):1012-1021.
PMID: 34308850
PMC: 8329672.
DOI: 10.12122/j.issn.1673-4254.2021.07.07.
Development and Validation of Novel Biomarkers Related to M2 Macrophages Infiltration by Weighted Gene Co-Expression Network Analysis in Prostate Cancer.
Xu N, Dong R, Lin T, Lin T, Lin Y, Chen S
Front Oncol. 2021; 11:634075.
PMID: 34268107
PMC: 8276177.
DOI: 10.3389/fonc.2021.634075.
KIF23 promotes triple negative breast cancer through activating epithelial-mesenchymal transition.
Jian W, Deng X, Munankarmy A, Borkhuu O, Ji C, Wang X
Gland Surg. 2021; 10(6):1941-1950.
PMID: 34268078
PMC: 8258877.
DOI: 10.21037/gs-21-19.